Great progress has been made over the past decade in understanding the structural, functional, and pharmacological diversity of lipid GPCRs. From the first determination of the crystal structure of bovine rhodopsin in 2000, much progress has been made in the field of GPCR structural biology. The extraordinary progress in structural biology and pharmacology of GPCRs, coupled with rapid advances in computational approaches to study receptor dynamics and receptor-ligand interactions, has broadened our comprehension of the structural and functional facets of the receptor family members and has helped usher in a modern age of structure-based drug design and development. First, we provide a primer on lipid mediators and lipid GPCRs and their role in physiology and diseases as well as their value as drug targets. Second, we summarize the current advancements in the understanding of structural features of lipid GPCRs, such as the structural variation of their extracellular domains, diversity of their orthosteric and allosteric ligand binding sites, and molecular mechanisms of ligand binding. Third, we close by collating the emerging paradigms and opportunities in targeting lipid GPCRs, including a brief discussion on current strategies, challenges, and the future outlook.
8 March 2024 in Journal of Chemical Information and Modeling
S-Adenosylmethionine (SAM)-dependent fluorinases have emerged as environmentally friendly enzymatic alternatives for organofluorine chemical synthesis. However, their use remains limited by their rarity; only 16 fluorinases have been found in nature so far. Here we report two new fluorinases, FLASbac from Streptosporangiales bacterium and a modified FLAAdig_Nter from Actinoplanes digitatis. Through molecular dynamics (MD) simulations, we have identified the crucial roles of the SAM-binding site and an ion-egress site (IES) for fluorination reaction, particularly regarding its preference for fluoride ions. We have validated these findings by testing mutants of the two new fluorinases and the known fluorinase from Streptomyces sp. MA37 (FLAMA37). Through these targeted mutations, we identified, for the first time, specific sites in certain variants that significantly enhance the enzyme's specificity for fluorination over chlorination while maintaining its fluorination activity. In these particular variants, this refinement led to a remarkable increase in fluorine preference, improving from approximately 10-fold to over 200-fold. Overall, this research advances our fundamental understanding of enzymatic fluorination, providing a basis for further exploration of fluorinase optimization. In turn, these advancements could open new opportunities for the pharmaceutical industry in the development of organofluorine drugs and other fluorine-reliant biotechnologies.
α-carbonic anhydrases (αCAs) underpin industrial carbon capture, yet natural enzymes are notoriously unstable under operational stresses. To overcome this limitation, a family-specific, fine-tuned protein language model (PLM) is developed and integrated with experimental validation to explore αCA sequence space beyond traditional protein design approaches. Although αCAs already operate near diffusion-limited rates (kcat ≈ 10 5 -10 6 s -1 ), the lead designed variant exhibited unprecedented robustness, remaining stable at 95 ºC and achieving a 1.8-fold increase in activity relative to the premier benchmark enzyme tdCA S82Y (stable up to 80 ºC; kcat ≈ 10 6 s -1 ). Despite sharing only 65.8% maximum sequence identity with the reference dataset, the engineered αCA enzyme outperforms all natural and ancestral counterparts. Computation-guided mutagenesis reveals distinct ligand-binding features absent in previously characterized αCAs, providing mechanistic insight into the enhanced performance. These findings demonstrate the utility of fine-tuned PLMs to access unexplored protein design space and establish a generalizable blueprint for engineering diverse protein families.
S-adenosyl methionine (SAM)-dependent fluorinases have emerged as environmentally friendly alternatives for organofluorine synthesis. However, their use are limited by their rarity; only 16 fluorinases have so far been found in nature, and with limited SAM substrate specificities. Here we report two new fluorinases, FLASbac from Streptosporangiales bacterium and the N-terminal modified FLAAdig_Nter from Actinoplanes digitatis. Through molecular dynamics (MD) simulations, we proposed the critical roles played by the SAM-binding site and an identified ion-egress site (IES) in the fluorinase function such as fluoride ion preference. We confirmed these findings by testing respective mutants of these two new fluorinases, along with the known fluorinase from Streptomyces sp. MA37 (FLAMA37). Specifically, with these identified mutations, for the first time, we have managed to maintain fluorinase activity while also improving specificity towards fluoride ions over chloride ions. Overall, this research advances our fundamental understanding of enzymatic fluorination, paving the way for the rational design of fluorinases. These advancements will aid the pharmaceutical industry in developing fluorine-containing drugs and other fluorine-reliant biotechnologies.